MedTech Dive January 20, 2023
From new product launches to regulatory changes that could expand CGM coverage, company executives and analysts share their predictions.
Diabetes technology companies including Dexcom and Medtronic are preparing for a year of new product launches and expected regulatory changes that could expand their customer base.
Dexcom is gearing up for a planned launch of its new G7 continuous glucose monitor in the U.S., while Insulet begins to roll out its new Omnipod 5 insulin pump in Europe. Meanwhile, Medtronic awaits a resolution to a Food and Drug Administration warning letter, which it received for a delayed recall after problems were identified with its MiniMed 600 series pumps, before it can seek clearance for new diabetes products.
Companies also are preparing...
Today's Sponsors
Today's Sponsor